Portola Pharmaceuticals, Inc. (PTLA) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
270 EAST GRAND AVENUE, SUITE 22 SOUTH SAN FRANCISCO, CA 94080 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
| 3/31/2020 Q1 | 12/31/2019 Q4 | 9/30/2019 Q3 | 6/30/2019 Q2 | 3/31/2019 Q1 | 12/31/2018 Q4 | 9/30/2018 Q3 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 429,283 | 476,807 | 273,938 | 322,841 | 316,964 | 369,984 | |||
| Cash and cash equivalents | 215,229 | 304,265 | 185,385 | 226,793 | 138,951 | 146,700 | |||
| Short-term investments | 214,054 | 172,542 | 88,553 | 96,048 | 178,013 | 223,284 | |||
| Restricted cash and investments | 3,421 | 3,201 | 2,280 | 1,528 | 1,062 | 272 | |||
| Receivables | 1,068 | ||||||||
| Inventory, net of allowances, customer advances and progress billings | 4,101 | 2,357 | 1,547 | 2,672 | 7,873 | 6,123 | |||
| Inventory | 4,101 | 2,357 | 1,547 | 2,672 | 7,873 | 6,123 | |||
| Prepaid expense | 2,359 | ||||||||
| Contract with customer, asset, after allowance for credit loss | 3,783 | 3,788 | 4,795 | 6,317 | 9,880 | ||||
| Other undisclosed current assets | 21,545 | 28,342 | 23,363 | 21,500 | 17,548 | 23,886 | |||
| Total current assets: | 462,133 | 514,495 | 305,923 | 354,858 | 353,327 | 403,692 | |||
| Noncurrent Assets | |||||||||
| Inventory, Noncurrent | 56,096 | 33,296 | 31,608 | 23,805 | 9,645 | 8,327 | |||
| Operating lease, right-of-use asset | ✕ | ✕ | |||||||
| Property, plant and equipment | 4,264 | 4,561 | 4,769 | 5,032 | 5,236 | 4,921 | |||
| Long-term investments and receivables | 36,961 | 10,881 | |||||||
| Long-term investments | 36,961 | 10,881 | |||||||
| Intangible assets, net (including goodwill), including: | 3,699 | 3,844 | 7,137 | 7,279 | 7,423 | ||||
| Intangible assets, net (excluding goodwill) | 3,699 | 3,844 | 7,137 | 7,279 | |||||
| Other undisclosed intangible assets, net (including goodwill) | 7,423 | ||||||||
| Prepaid expense | 38 | ||||||||
| Other undisclosed noncurrent assets | 19,029 | 21,134 | 20,353 | 9,550 | 10,894 | 12,461 | |||
| Total noncurrent assets: | 116,350 | 62,690 | 60,574 | 45,524 | 33,092 | 44,013 | |||
| TOTAL ASSETS: | 578,483 | 577,185 | 366,497 | 400,382 | 386,419 | 447,705 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 28,838 | 27,240 | 26,049 | 17,160 | 31,212 | 29,201 | |||
| Employee-related liabilities | 16,099 | 13,480 | 14,217 | 7,412 | 10,794 | 8,197 | |||
| Accounts payable | 12,739 | 13,760 | 11,832 | 9,748 | 13,215 | 15,163 | |||
| Accrued liabilities | 7,203 | 5,841 | |||||||
| Deferred revenue | ✕ | ✕ | |||||||
| Debt | 19,034 | 24,189 | 19,567 | 15,079 | 11,802 | 9,395 | |||
| Deferred rent credit | 960 | 940 | |||||||
| Other liabilities | 5,361 | 9,457 | 8,741 | 9,747 | 2,473 | 1,815 | |||
| Contract with customer, liability | ✕ | 1,623 | 1,061 | 1,267 | 2,212 | 1,847 | 2,358 | ||
| Other undisclosed current liabilities | 47,562 | 25,544 | 28,683 | 29,630 | 20,711 | 17,372 | |||
| Total current liabilities: | 102,418 | 87,491 | 84,307 | 73,828 | 69,005 | 61,081 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 118,096 | 57,269 | 57,061 | 56,839 | 155,256 | 152,675 | |||
| Long-term debt, excluding current maturities | 118,096 | 57,269 | 57,061 | 56,839 | 155,256 | 152,675 | |||
| Liabilities, other than long-term debt | 8,237 | 5,839 | 6,400 | 8,841 | 16,412 | 10,743 | |||
| Deferred revenue | ✕ | ✕ | |||||||
| Contract with customer, liability | ✕ | 4,352 | 4,399 | 4,415 | 4,426 | 4,488 | 5,085 | ||
| Other liabilities | 3,885 | 1,440 | 1,985 | 4,415 | 11,924 | 5,658 | |||
| Operating lease, liability | ✕ | ✕ | |||||||
| Other undisclosed noncurrent liabilities | 219,907 | 213,698 | 218,135 | 210,224 | 55,179 | 56,278 | |||
| Total noncurrent liabilities: | 346,240 | 276,806 | 281,596 | 275,904 | 226,847 | 219,696 | |||
| Total liabilities: | 448,658 | 364,297 | 365,903 | 349,732 | 295,852 | 280,777 | |||
| Equity | |||||||||
| Equity, attributable to parent | 129,825 | 212,888 | 594 | 48,422 | 88,401 | 164,424 | |||
| Common stock | 80 | 79 | 70 | 70 | 68 | 67 | |||
| Additional paid in capital | 1,946,077 | 1,932,428 | 1,670,627 | 1,652,292 | 1,614,320 | 1,601,950 | |||
| Accumulated other comprehensive income (loss) | 35 | 72 | (39) | (80) | (283) | (437) | |||
| Accumulated deficit | (1,816,367) | (1,719,691) | (1,670,064) | (1,603,860) | (1,525,704) | (1,437,156) | |||
| Equity, attributable to noncontrolling interest | 2,228 | 2,166 | 2,504 | ||||||
| Total equity: | 129,825 | 212,888 | 594 | 50,650 | 90,567 | 166,928 | |||
| TOTAL LIABILITIES AND EQUITY: | 578,483 | 577,185 | 366,497 | 400,382 | 386,419 | 447,705 | |||
Income Statement (P&L) ($ in thousands)Annual | Quarterly
| 3/31/2020 Q1 | 12/31/2019 Q4 | 9/30/2019 Q3 | 6/30/2019 Q2 | 3/31/2019 Q1 | 12/31/2018 Q4 | 9/30/2018 Q3 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 29,248 | 36,799 | 28,424 | 22,169 | 15,298 | 14,177 | ||
| Cost of revenue (Cost of Goods and Services Sold) | (29,553) | (2,684) | (4,991) | (7,150) | (12,401) | (4,292) | ||
| Gross profit: | (305) | 34,115 | 23,433 | 15,019 | 2,897 | 9,885 | ||
| Operating expenses | (89,838) | (77,697) | (87,393) | (88,618) | (90,078) | (79,029) | ||
| Operating loss: | (90,143) | (43,582) | (63,960) | (73,599) | (87,181) | (69,144) | ||
| Nonoperating income (expense) | 1,740 | 1,953 | 4,021 | 1,984 | 4,393 | 3,924 | ||
| Interest and debt expense | (8,273) | (7,998) | (8,538) | (6,481) | (6,098) | (5,957) | ||
| Loss from continuing operations: | (96,676) | (49,627) | (68,477) | (78,096) | (88,886) | (71,177) | ||
| Loss before gain (loss) on sale of properties: | (96,676) | (49,627) | (68,477) | (78,096) | (88,886) | (71,177) | ||
| Net loss: | (96,676) | (49,627) | (68,477) | (78,096) | (88,886) | (71,177) | ||
| Net income (loss) attributable to noncontrolling interest | 2,273 | (60) | 338 | (126) | ||||
| Net loss available to common stockholders, diluted: | (96,676) | (49,627) | (66,204) | (78,156) | (88,548) | (71,303) | ||
Comprehensive Income ($ in thousands)Annual | Quarterly
| 3/31/2020 Q1 | 12/31/2019 Q4 | 9/30/2019 Q3 | 6/30/2019 Q2 | 3/31/2019 Q1 | 12/31/2018 Q4 | 9/30/2018 Q3 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (96,676) | (49,627) | (68,477) | (78,096) | (88,886) | (71,177) | ||
| Other comprehensive income | 111 | 83 | 203 | |||||
| Other undisclosed comprehensive income (loss) | (112) | (42) | 154 | 237 | ||||
| Comprehensive loss: | (96,788) | (49,516) | (68,436) | (77,893) | (88,732) | (70,940) | ||
| Comprehensive income (loss), net of tax, attributable to noncontrolling interest | 2,273 | (60) | 338 | (126) | ||||
| Comprehensive loss, net of tax, attributable to parent: | (96,788) | (49,516) | (66,163) | (77,953) | (88,394) | (71,066) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.